Toward the harmonization of immune monitoring in clinical trials: quo vadis?

Cancer Immunol Immunother. 2008 Mar;57(3):285-8. doi: 10.1007/s00262-007-0379-z. Epub 2007 Aug 25.

Authors

C M Britten¹, S Janetzki, S H van der Burg, C Gouttefangeas, A Hoos

Affiliation

¹ Department of Immunohaematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands. [email protected]

No abstract available

Publication types

Comment

MeSH terms

Clinical Trials as Topic
Humans
Immunotherapy*
Monitoring, Immunologic / standards*
Neoplasms / therapy*
Predictive Value of Tests